chr5-90840606-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032119.4(ADGRV1):c.16640G>A(p.Arg5547His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000646 in 1,610,544 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000105 AC: 26AN: 247702Hom.: 1 AF XY: 0.0000968 AC XY: 13AN XY: 134328
GnomAD4 exome AF: 0.0000514 AC: 75AN: 1458306Hom.: 1 Cov.: 31 AF XY: 0.0000566 AC XY: 41AN XY: 725014
GnomAD4 genome AF: 0.000190 AC: 29AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74450
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 14, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 25, 2022 | Reported in a patient with Meniere's disease in published literature (Roman-Naranjo et al., 2021); this patient also was found to have a heterozygous MYO7A variant; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27149842, 34391192) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 08, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Arg5547His va riant in GPR98 has not been previously reported in individuals with hearing loss , but has been identified in 12/117174 chromosomes across multiple populations b y the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs200907244). The arginine (Arg) at position 5547 is not conserved in mammals or evolutionarily distant species, with 1 mammal (manatee) having a histidine (His ) at this position, suggesting that this change may be tolerated. Additional com putational prediction tools suggest that the p.Arg5547His variant may not impact the protein, though this information is not predictive enough to rule out patho genicity. In summary, while the clinical significance of the p.Arg5547His varian t is uncertain, its lack of evolutionarily conservation suggests that it is more likely to be benign. - |
Usher syndrome type 2C Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Laboratory of Prof. Karen Avraham, Tel Aviv University | Dec 25, 2024 | The ADGRV1 c.16640G>A:p.(Arg5547His) rare, possibly deleterioos variant, was detected in an individual with sloping normal-to-severe HL, that also carried two CDH23 VUSs, c.9629T>C:p.(Ile3210Thr) and c.7849G>C:p.(Gly2617Arg), suggesting digenic inheritance of ADGRV1/CDH23. - |
Meniere disease Uncertain:1
Uncertain significance, criteria provided, single submitter | case-control | Otology & Neurotology- Genomics of vestibular disorders (CTS-495), Jose Antonio López Escámez, Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica (GENYO) | Jun 21, 2021 | Digenic inheritance along with NM_000260.4:c.2617C>T(MYO7A) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at